BANK OF AMERICA CORP /DE/ - LUMOS PHARMA INC ownership

LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 38 filers reported holding LUMOS PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of LUMOS PHARMA INC
ValueSharesWeighting
Q3 2023$5,9400.0%1,8000.0%0.00%
Q2 2023$5,940
-0.3%
1,8000.0%0.00%
Q1 2023$5,958
+13440.9%
1,800
+14900.0%
0.00%
Q4 2022$4412
+20.0%
0.00%
Q4 2021$010
-47.4%
0.00%
Q2 2021$019
+46.2%
0.00%
Q1 2021$0
-100.0%
13
-99.8%
0.00%
Q4 2020$213,000
+88.5%
5,975
-27.0%
0.00%
Q3 2020$113,000
-16.3%
8,185
+0.2%
0.00%
Q2 2020$135,000
+95.7%
8,1650.0%0.00%
Q1 2020$69,0008,1650.00%
Other shareholders
LUMOS PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Acuitas Investments, LLC 153,867$507,7610.30%
Lion Point Capital, LP 78,351$258,5580.12%
Minerva Advisors LLC 26,549$840.06%
Wealth Advisors of Iowa, LLC 11,699$38,6060.03%
Marquette Asset Management, LLC 31,088$102,5910.02%
Greenwich Wealth Management LLC 49,002$1620.02%
Key FInancial Inc 10,927$36,0590.01%
Paladin Advisory Group, LLC 4,387$14,4770.01%
Blackstone Inc. 468,145$1,544,8790.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 47,643$157,2220.00%
View complete list of LUMOS PHARMA INC shareholders